Autoimmunity is an example of the potent and destructive function expressed by the immune system when normal constraints against self reactivity are lost or compromised. The study of mechanisms providing insight into the development of AI is not only of great clinical importance, but, moreover, may yield important insights into the manner in which control over immune function is normally regulated. This proposal has developed from findings, both our own as well as those of others, that have revealed a dramatic defect in cytokine (CK) expression in macrophages (mphi) from autoimmune- prone (AIP) mice.
The specific aims are directed towards an understanding of the potential relationship of this defect to the development of autoreactivity, as well as defining the molecular basis of this dysregulation. The potential importance of this observation is supported by the findings that the defect is among the earliest known immunological problems in AIP mice, and appears to be diagnostic for strains associated with lupus-like disease. Moreover, critical involvement of CK in the regulation of lymphocyte growth and function is well-documented.
The specific aims are (1) to evaluate CK production in vivo and in vitro, and relate it temporally and anatomically to the development of autoreactive T cells (ART). We will (a) determine CK mRNA and protein content in mphi isolated from a number of tissues during several stages of ontogeny of N and AIP mice; (b) quantitate ART by limiting dilution, and compare to the induction of KLH-reactive T cells, to determine if there is an association of ART development with endogenous regulation of CK, and if the response to self and foreign ags is similar; (c) study the in vivo induction of CK, using cloned ART as a stimulus; (d) study AIP --> N chimera to determine if the mphi defect is truly intrinsic; (2) to determine how the defective process of CK expression is initiated. We will (a) define the role of adherence in the aberrant regulation of CK in AIP mphi. In particular, we will evaluate pathways which might account for such regulation in situ, ie, interaction of these mphi with ART or extracellular matrix proteins; (b) evaluate signal transduction in N and AIP mphi, focusing initially on two pathways that may relate to the events that we have observed: the differential regulation of IL-1 and TNF by specific kinases, and the adherence-mediated induction of cellular proto-oncogenes; and (3) to characterize the mechanism(s) which account for the aberrant regulation of CK genes in mphi from AIP mice. The mechanism(s) accounting for the limited and transient expression of CK mRNA in MRL/+ mphi will be determined by (a) transcriptional elongation and attenuation (by nuclear run on analysis), and (b) mRNA stability (using an in vitro mRNA decay system) at various times following the stimulation of the mphi. The role of newly synthesized proteins in these processes will also be examined. We believe that this approach should identify key aspects of the in vivo regulation of CK expression in AIP animals and its correlation with both the development of ART and the progression of disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI031418-01A1
Application #
3146427
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1992-04-01
Project End
1995-03-30
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Boston University
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02118
Liu, Jiajian; Beller, David (2002) Aberrant production of IL-12 by macrophages from several autoimmune-prone mouse strains is characterized by intrinsic and unique patterns of NF-kappa B expression and binding to the IL-12 p40 promoter. J Immunol 169:581-6
Alleva, D G; Pavlovich, R P; Grant, C et al. (2000) Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese Diabetes 49:1106-15
Alleva, D G; Kaser, S B; Beller, D I (1998) Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain. J Immunol 161:6878-84
Levine, J S; Koh, J S; Hartwell, D et al. (1998) Adhesion elicits an intrinsic defect in interleukin-1 expression by macrophages from autoimmune-prone MRL mice. J Autoimmun 11:141-50
Kung, J T; Beller, D; Ju, S T (1998) Lymphokine regulation of activation-induced apoptosis in T cells of IL-2 and IL-2R beta knockout mice. Cell Immunol 185:158-63
Alleva, D G; Kaser, S B; Monroy, M A et al. (1997) IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J Immunol 159:2941-51
Alleva, D G; Kaser, S B; Beller, D I (1997) Aberrant cytokine expression and autocrine regulation characterize macrophages from young MRL+/+ and NZB/W F1 lupus-prone mice. J Immunol 159:5610-9
Fitzpatrick, J M; Koh, J S; Hartwell, D et al. (1996) Dysregulated cytokine expression in vivo in prediseased and diseased autoimmune-prone MRL mice. Autoimmunity 23:217-29
Hartwell, D W; Fenton, M J; Levine, J S et al. (1995) Aberrant cytokine regulation in macrophages from young autoimmune-prone mice: evidence that the intrinsic defect in MRL macrophage IL-1 expression is transcriptionally controlled. Mol Immunol 32:743-51
Hartwell, D; Levine, J; Fenton, M et al. (1994) Cytokine dysregulation and the initiation of systemic autoimmunity. Immunol Lett 43:15-21

Showing the most recent 10 out of 11 publications